Literature DB >> 22580636

Management of ejaculatory disorders in infertile men.

Yagil Barazani1, Peter J Stahl, Harris M Nagler, Doron S Stember.   

Abstract

Ejaculatory dysfunction is a highly prevalent clinical condition that may be classified along a continuum that ranges from premature ejaculation (PE), through retarded or delayed ejaculation (DE), to complete anejaculation (AE). Retrograde ejaculation (RE) represents a distinct entity in which ejaculate is expelled either partially or completely into the bladder. While DE and PE are significant sources of sexual dissatisfaction among men and their partners, patients with these disorders retain normal fertility in most cases. Conversely, men with AE and RE are unable to deliver sperm into the female genital tract and are therefore rendered subfertile. Therefore, in reviewing ejaculatory disorders as they relate to fertility, this paper will primarily focus on the diagnosis and management of AE and RE. Physiology, diagnostic strategies, pharmacological treatments, and procedural interventions relevant to AE and RE are discussed.

Entities:  

Mesh:

Year:  2012        PMID: 22580636      PMCID: PMC3720079          DOI: 10.1038/aja.2012.29

Source DB:  PubMed          Journal:  Asian J Androl        ISSN: 1008-682X            Impact factor:   3.285


  39 in total

Review 1.  Retrograde ejaculation.

Authors:  A Hershlag; S F Schiff; A H DeCherney
Journal:  Hum Reprod       Date:  1991-02       Impact factor: 6.918

Review 2.  Effect of diabetes mellitus upon male reproductive function.

Authors:  W J Sexton; J P Jarow
Journal:  Urology       Date:  1997-04       Impact factor: 2.649

3.  Successful pregnancies from men with retrograde ejaculation with the use of washed sperm and gamete intrafallopian tube transfer (GIFT).

Authors:  M Vernon; E Wilson; K Muse; S Estes; T Curry
Journal:  Fertil Steril       Date:  1988-11       Impact factor: 7.329

Review 4.  Retrograde ejaculation.

Authors:  H Yavetz; L Yogev; R Hauser; J B Lessing; G Paz; Z T Homonnai
Journal:  Hum Reprod       Date:  1994-03       Impact factor: 6.918

5.  Imipramine for successful treatment of retrograde ejaculation caused by retroperitoneal surgery.

Authors:  R Ochsenkühn; A Kamischke; E Nieschlag
Journal:  Int J Androl       Date:  1999-06

6.  Nerve sparing post-chemotherapy retroperitoneal lymph node dissection for advanced testicular cancer.

Authors:  C L Coogan; M J Hejase; G R Wahle; R S Foster; R G Rowland; R Bihrle; J P Donohue
Journal:  J Urol       Date:  1996-11       Impact factor: 7.450

7.  Tamsulosin 0.4 mg once daily: effect on sexual function in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction.

Authors:  K Höfner; H Claes; T M De Reijke; B Folkestad; M J Speakman
Journal:  Eur Urol       Date:  1999-10       Impact factor: 20.096

8.  Pregnancy after assisted ejaculation procedures in men with spinal cord injury.

Authors:  J Sønksen; P Sommer; F Biering-Sørensen; S Ziebe; A Lindhard; A Loft; A N Andersen; J K Kristensen
Journal:  Arch Phys Med Rehabil       Date:  1997-10       Impact factor: 3.966

9.  Imipramine for the treatment of sterility in patients following retroperitoneal lymph node dissection.

Authors:  B Goldwasser; I Madgar; P Jonas; B Lunenfeld; M Many
Journal:  Andrologia       Date:  1983       Impact factor: 2.775

10.  Premature ejaculation in infertile couples: prevalence and correlates.

Authors:  Alan W Shindel; Christian J Nelson; Cathy K Naughton; John P Mulhall
Journal:  J Sex Med       Date:  2007-12-14       Impact factor: 3.802

View more
  12 in total

1.  Lisdexamfetamine Dimesylate (Vyvanse) for the Treatment of Neurogenic Anejaculation.

Authors:  Matthew D Lyons; Aaron C Lentz; Robert M Coward
Journal:  Am J Mens Health       Date:  2016-07-11

Review 2.  Sexual dysfunction and male infertility.

Authors:  Francesco Lotti; Mario Maggi
Journal:  Nat Rev Urol       Date:  2018-03-13       Impact factor: 14.432

3.  MR imaging of the prostate and adjacent anatomic structures before, during, and after ejaculation: qualitative and quantitative evaluation.

Authors:  Milica Medved; Steffen Sammet; Ambereen Yousuf; Aytekin Oto
Journal:  Radiology       Date:  2014-02-01       Impact factor: 11.105

Review 4.  Infertility, impotence, and emasculation--psychosocial contexts for abandoning reproduction.

Authors:  Erik Wibowo; Thomas W Johnson; Richard J Wassersug
Journal:  Asian J Androl       Date:  2016 May-Jun       Impact factor: 3.285

5.  Randomized Crossover Trial of Amoxapine Versus Vitamin B12 for Retrograde Ejaculation.

Authors:  Jianlin Hu; Koichi Nagao; Toshihiro Tai; Hideyuki Kobayashi; Koichi Nakajima
Journal:  Int Braz J Urol       Date:  2017 May-Jun       Impact factor: 1.541

6.  Diagnosis of Partial Retrograde Ejaculation in Non-Azoospermic Infertile Men with Low Semen Volume.

Authors:  Roger Mieusset; Marie Walschaerts; François Isus; Thierry Almont; Myriam Daudin; Safouane M Hamdi
Journal:  PLoS One       Date:  2017-01-06       Impact factor: 3.240

7.  Understanding the seminal plasma proteome and its role in male fertility.

Authors:  Mariana Camargo; Paula Intasqui; Ricardo Pimenta Bertolla
Journal:  Basic Clin Androl       Date:  2018-06-04

Review 8.  Contemporary management of ejaculatory dysfunction.

Authors:  Marisa Gray; Jacqueline Zillioux; Iyad Khourdaji; Ryan P Smith
Journal:  Transl Androl Urol       Date:  2018-08

9.  Transurethral resection of the prostate with preservation of the bladder neck decreases postoperative retrograde ejaculation.

Authors:  Jie Liao; Xiaobo Zhang; Mingquan Chen; Dongjie Li; Xinji Tan; Jie Gu; Sheng Hu; Xiong Chen
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2018-11-14       Impact factor: 1.195

10.  Psychological burden prediction based on demographic variables among infertile men with sexual dysfunction.

Authors:  Hai-Ming Cao; Zi Wan; Yong Gao; Jun-Long Zhang; Yan Zhang; Hai-Peng Xiao; Xiang-An Tu; Xiang-Zhou Sun; Chun-Hua Deng
Journal:  Asian J Androl       Date:  2019 Mar-Apr       Impact factor: 3.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.